Hyperthyroidism: A Review
Open accessThe DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Abstract
Importance: Overt hyperthyroidism, defined as suppressed thyrotropin (previously thyroid-stimulating hormone) and high concentration of triiodothyronine (T 3) and/or free thyroxine (FT 4), affects approximately 0.2% to 1.4% of people worldwide. Subclinical hyperthyroidism, defined as low concentrations of thyrotropin and normal concentrations of T 3 and FT 4, affects approximately 0.7% to 1.4% of people worldwide. Untreated hyperthyroidism can cause cardiac arrhythmias, heart failure, osteoporosis, and adverse pregnancy outcomes. It may lead to unintentional weight loss and is associated with increased mortality. Observations: The most common cause of hyperthyroidism is Graves disease, with a global prevalence of 2% in women and 0.5% in men. Other causes of hyperthyroidism and thyrotoxicosis include toxic nodules and the thyrotoxic phase of thyroiditis. Common symptoms of thyrotoxicosis include anxiety, insomnia, palpitations, unintentional weight loss, diarrhea, and heat intolerance. Patients with Graves disease may have a diffusely enlarged thyroid gland, stare, or exophthalmos on examination. Patients with toxic nodules (ie, in which thyroid nodules develop autonomous function) may have symptoms from local compression of structures in the neck by the thyroid gland, such as dysphagia, orthopnea, or voice changes. Etiology can typically be established based on clinical presentation, thyroid function tests, and thyrotropin-receptor antibody status. Thyroid scintigraphy is recommended if thyroid nodules are present or the etiology is unclear. Thyrotoxicosis from thyroiditis may be observed if symptomatic or treated with supportive care. Treatment options for overt hyperthyroidism from autonomous thyroid nodules or Graves disease include antithyroid drugs, radioactive iodine ablation, and surgery. Treatment for subclinical hyperthyroidism is recommended for patients at highest risk of osteoporosis and cardiovascular disease, such as those older than 65 years or with persistent serum thyrotropin level less than 0.1 mIU/L. Conclusions and Relevance: Hyperthyroidism affects 2.5% of adults worldwide and is associated with osteoporosis, heart disease, and increased mortality. First-line treatments are antithyroid drugs, thyroid surgery, and radioactive iodine treatment. Treatment choices should be individualized and patient centered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stagnaro-Green, A., Abalovich, M., Alexander, E., Azizi, F., Mestman, J., Negro, R., Nixon, A., Pearce, E. N., Soldin, O. P., Sullivan, S., et al. (2011) · Thyroid · doi:10.1089/thy.2011.0087 · Cited by 2,942
Self-citationRoss, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938
Alexander, E. K., Pearce, E. N., Brent, G. A., Brown, R. S., Chen, H., Dosiou, C., Grobman, W. A., Laurberg, P., Lazarus, J. H., Mandel, S. J., et al. (2017) · Thyroid® · doi:10.1089/thy.2016.0457 · Cited by 2,731
Self-citationPhysiological and Molecular Basis of Thyroid Hormone Action
Yen, P. M. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1097 · Cited by 2,011
Global epidemiology of hyperthyroidism and hypothyroidism
Taylor, P. N., Albrecht, D., Scholz, A., Gutierrez-Buey, G., Lazarus, J. H., Dayan, C. M., & Okosieme, O. E. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.18 · Cited by 1,552
Bartalena, L., Kahaly, G. J., Baldeschi, L., Dayan, C. M., Eckstein, A., Marcocci, C., Marinò, M., Vaidya, B., Wiersinga, W. M., _, _., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0479 · Cited by 1,054
Life-Threatening Thyrotoxicosis: Thyroid Storm
Burch, H. B., & Wartofsky, L. (1993) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30165-8 · Cited by 852
Systematic review and meta-analysis of predictors of post-thyroidectomy hypocalcaemia
Edafe, O., Antakia, R., Laskar, N., Uttley, L., & Balasubramanian, S. P. (2014) · British Journal of Surgery · doi:10.1002/bjs.9384 · Cited by 732
Subclinical hyperthyroidism and the risk of coronary heart disease and mortality
Collet, T.-H., Gussekloo, J., Bauer, D. C., den Elzen, W. P. J., Cappola, A. R., Balmer, P., Iervasi, G., Åsvold, B. O., Sgarbi, J. A., Völzke, H., et al. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.402 · Cited by 572
Patel, K. N., Yip, L., Lubitz, C. C., Grubbs, E. G., Miller, B. S., Shen, W., Angelos, P., Chen, H., Doherty, G. M., Fahey, T. J., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003580 · Cited by 541
Papini, E., Monpeyssen, H., Frasoldati, A., & Hegedüs, L. (2020) · European Thyroid Journal · doi:10.1159/000508484 · Cited by 476
Laurberg, P., Wallin, G., Tallstedt, L., Abraham-Nordling, M., Lundell, G., & Tørring, O. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0450 · Cited by 428
Davies, T. F., Andersen, S., Latif, R., Nagayama, Y., Barbesino, G., Brito, M., Eckstein, A. K., Stagnaro-Green, A., & Kahaly, G. J. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0184-y · Cited by 398
Is There a Minimum Number of Thyroidectomies a Surgeon Should Perform to Optimize Patient Outcomes?
Adam, M. A., Thomas, S., Youngwirth, L., Hyslop, T., Reed, S. D., Scheri, R. P., Roman, S. A., & Sosa, J. A. (2017) · Annals of Surgery · doi:10.1097/sla.0000000000001688 · Cited by 381
LAURBERG, P., PEDERSEN, K. M., VESTERGAARD, H., & SIGURDSSON, G. (1991) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1991.tb00368.x · Cited by 361
A 2011 Survey of Clinical Practice Patterns in the Management of Graves' Disease
Burch, H. B., Burman, K. D., & Cooper, D. S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2802 · Cited by 345
Subclinical Thyroid Dysfunction and Fracture Risk: A Meta-analysis
Blum, M. R., Bauer, D. C., Collet, T.-H., Fink, H. A., Cappola, A. R., da Costa, B. R., Wirth, C. D., Peeters, R. P., Åsvold, B. O., den Elzen, W. P. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.5161 · Cited by 343
Biondi, B., Bartalena, L., Cooper, D. S., Hegedüs, L., Laurberg, P., & Kahaly, G. J. (2015) · European Thyroid Journal · doi:10.1159/000438750 · Cited by 323
The Danish investigation on iodine intake and thyroid disease, DanThyr: status and perspectives
Laurberg, P., Jørgensen, T., Perrild, H., Ovesen, L., Knudsen, N., Pedersen, I. B., Rasmussen, L. B., Carlé, A., & Vejbjerg, P. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02210 · Cited by 296
Extrathyroidal manifestations of Graves’ disease: a 2014 update
Bartalena, L., & Fatourechi, V. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0097-2 · Cited by 279
Interferences With Thyroid Function Immunoassays: Clinical Implications and Detection Algorithm
Favresse, J., Burlacu, M.-C., Maiter, D., & Gruson, D. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00119 · Cited by 258
Satoh, T., Isozaki, O., Suzuki, A., Wakino, S., Iburi, T., Tsuboi, K., Kanamoto, N., Otani, H., Furukawa, Y., Teramukai, S., et al. (2016) · Endocrine Journal · doi:10.1507/endocrj.ej16-0336 · Cited by 251
Sundaresh, V., Brito, J. P., Wang, Z., Prokop, L. J., Stan, M. N., Murad, M. H., & Bahn, R. S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1954 · Cited by 250
Prevalence of Postpartum Thyroid Dysfunction: A Quantitative Review
Nicholson, W. K., Robinson, K. A., Smallridge, R. C., Ladenson, P. W., & Powe, N. R. (2006) · Thyroid · doi:10.1089/thy.2006.16.573 · Cited by 216
Thyroid Disease in Pregnancy: ACOG Practice Bulletin, Number 223
(2020) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003893 · Cited by 212
Assessment and treatment of thyroid disorders in pregnancy and the postpartum period
Lee, S. Y., & Pearce, E. N. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00604-z · Cited by 206
Self-citationVos, X. G., Endert, E., Zwinderman, A. H., Tijssen, J. G. P., & Wiersinga, W. M. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3644 · Cited by 188
Vadiveloo, T., Donnan, P. T., Cochrane, L., & Leese, G. P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2693 · Cited by 186
Rugge, J. B., Bougatsos, C., & Chou, R. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1456 · Cited by 172
Galindo, R. J., Hurtado, C., Pasquel, F. J., Tome, R. G., Peng, L., & Umpierrez, G. E. (2018) · Thyroid · doi:10.1089/thy.2018.0275 · Cited by 161
Faber, Jensen, Petersen, Nygaard, Hegedüs, & Siersbæk‐Nielsen (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00427.x · Cited by 156
Thyroid hormone replacement after thyroid lobectomy
Stoll, S. J., Pitt, S. C., Liu, J., Schaefer, S., Sippel, R. S., & Chen, H. (2009) · Surgery · doi:10.1016/j.surg.2009.06.026 · Cited by 150
Biondi, B., & Cooper, D. S. (2018) · New England Journal of Medicine · doi:10.1056/nejmcp1709318 · Cited by 135
Bone metabolism during anti‐thyroid drug treatment of endogenous subclinical hyperthyroidism
Mudde, A. H., Houben, A. J. H. M., & Kruseman, A. C. N. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02571.x · Cited by 135
Nyström, H. F., Jansson, S., & Berg, G. (2013) · Clinical Endocrinology · doi:10.1111/cen.12060 · Cited by 134
Azizi, F., Amouzegar, A., Tohidi, M., Hedayati, M., Khalili, D., Cheraghi, L., Mehrabi, Y., & Takyar, M. (2019) · Thyroid · doi:10.1089/thy.2019.0180 · Cited by 134
Okosieme, O. E., Taylor, P. N., Evans, C., Thayer, D., Chai, A., Khan, I., Draman, M. S., Tennant, B., Geen, J., Sayers, A., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30059-2 · Cited by 131
Brito, J. P., Payne, S. R., Ospina, N. S., Rodríguez‐Gutiérrez, R., Maraka, S., Sangaralingham, L. R., Iñiguez‐Ariza, N. M., Montori, V. M., & Stan, M. N. (2020) · Thyroid · doi:10.1089/thy.2019.0132 · Cited by 127
Thyroid Storm in the ICU: A Retrospective Multicenter Study
Bourcier, S., Coutrot, M., Kimmoun, A., Sonneville, R., de Montmollin, É., Persichini, R., Schnell, D., Charpentier, J., Aubron, C., Morawiec, É., et al. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000004078 · Cited by 126
Carella, C., Mazziotti, G., Sorvillo, F., Piscopo, M., Cioffi, M., Pilla, P., Nersita, R., Iorio, S., Amato, G., Braverman, L. E., et al. (2006) · Thyroid · doi:10.1089/thy.2006.16.295 · Cited by 119
Lillevang-Johansen, M., Abrahamsen, B., Jørgensen, H. L., Brix, T. H., & Hegedüs, L. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00166 · Cited by 112
New Therapeutic Horizons for Graves’ Hyperthyroidism
Lane, L. C., Cheetham, T. D., Perros, P., & Pearce, S. H. S. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa022 · Cited by 110
Ceccarelli, C., Bencivelli, W., Vitti, P., Grasso, L., & Pinchera, A. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02218.x · Cited by 109
Villagelin, D., Romaldini, J. H., dos Santos, R. B., Milkos, A. B. B. P., & Ward, L. S. (2015) · Thyroid · doi:10.1089/thy.2015.0195 · Cited by 109
Antithyroid Drug-Induced Agranulocytosis: State of the Art on Diagnosis and Management
Vicente, N., Cardoso, L., Barros, L. M., & Carrilho, F. (2017) · Drugs in R&D · doi:10.1007/s40268-017-0172-1 · Cited by 105
Thyroid Dysfunction and Sleep Disorders
Green, M. E., Bernet, V., & Cheung, J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.725829 · Cited by 103
The Long-Term Outcome of Treatment for Graves' Hyperthyroidism
Sjölin, G., Holmberg, M., Törring, O., Byström, K., Khamisi, S., de Laval, D., Abraham-Nordling, M., Calissendorff, J., Lantz, M., Hallengren, B., et al. (2019) · Thyroid · doi:10.1089/thy.2019.0085 · Cited by 102
de los Santos, E. T. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390030032006 · Cited by 92
Dekkers, O. M., Horváth-Puhó, E., Cannegieter, S. C., Vandenbroucke, J. P., Sørensen, H. T., & Jørgensen, J. O. L. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0576 · Cited by 85
Immune checkpoint inhibitor-related thyroid dysfunction
Iwama, S., Kobayashi, T., Yasuda, Y., & Arima, H. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101660 · Cited by 85
Shim, S. R., Kitahara, C. M., Cha, E. S., Kim, S., Bang, Y. J., & Lee, W. J. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.25072 · Cited by 82
Scappaticcio, L., Trimboli, P., Keller, F., Imperiali, M., Piccardo, A., & Giovanella, L. (2019) · Clinical Endocrinology · doi:10.1111/cen.14130 · Cited by 80
Abnormal Liver Blood Tests in Patients with Hyperthyroidism: Systematic Review and Meta-Analysis
Scappaticcio, L., Longo, M., Maiorino, M. I., Pernice, V., Caruso, P., Esposito, K., & Bellastella, G. (2020) · Thyroid · doi:10.1089/thy.2020.0715 · Cited by 80
Guo, Z., Yu, P., Liu, Z., Si, Y., & Jin, M. (2013) · Clinical Endocrinology · doi:10.1111/cen.12209 · Cited by 68
Risk of perioperative thyroid storm in hyperthyroid patients: a systematic review
de Mul, N., Damstra, J., van Dijkum, E. J. M. N., Fischli, S., Kalkman, C. J., Schellekens, W. M., & Immink, R. V. (2021) · British Journal of Anaesthesia · doi:10.1016/j.bja.2021.06.043 · Cited by 67
Ippolito, S., Cusini, C., Lasalvia, P., Gianfagna, F., Veronesi, G., Gallo, D., Masiello, E., Premoli, P., Sabatino, J., Mercuriali, A., et al. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01479-z · Cited by 66
Balavoine, A.-S., Glinoer, D., Dubucquoi, S., & Wémeau, J.-L. (2015) · Thyroid® · doi:10.1089/thy.2014.0603 · Cited by 65
Consequences of hyperthyroidism in male and female fertility: pathophysiology and current management
Mintziori, G., Kita, M. D., Duntas, L. H., & Goulis, D. G. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0452-6 · Cited by 62
Yu, W., Wu, N., Li, L., Wang, J., Ouyang, H., & Shen, H. (2019) · Endocrine Practice · doi:10.4158/ep-2019-0221 · Cited by 60
Sohn, S. Y., Lee, E., Lee, M. K., & Lee, J. H. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.728 · Cited by 60
Immune Related Adverse Events of the Thyroid – A Narrative Review
Muir, C. A., Tsang, V., Menzies, A. M., & Clifton-Bligh, R. J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.886930 · Cited by 60
Shi, H., Sheng, R., Hu, Y., Liu, X., Jiang, L., Wang, Z., & Cui, D. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.01.022 · Cited by 57
Brito, J. P., Castaneda-Guarderas, A., Gionfriddo, M. R., Singh Ospina, N., Maraka, S., Dean, D. S., Castro, M. R., Fatourechi, V., Gharib, H., Stan, M. N., et al. (2015) · Thyroid · doi:10.1089/thy.2015.0277 · Cited by 56
Schouten, B. J., Brownlie, B. E. W., Frampton, C. M., & Turner, J. G. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03908.x · Cited by 55
COVID-induced thyroid autoimmunity
Brancatella, A., Viola, N., Santini, F., & Latrofa, F. (2023) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2023.101742 · Cited by 55
Thyrotropin, Hyperthyroidism, and Bone Mass
Kim, S., Ryu, V., Miyashita, S., Korkmaz, F., Lizneva, D., Gera, S., Latif, R., Davies, T. F., Iqbal, J. Z., Yuen, T., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab548 · Cited by 54
Comparison of Propylthiouracil vs Methimazole for Thyroid Storm in Critically Ill Patients
Lee, S. Y., Modzelewski, K. L., Law, A. C., Walkey, A. J., Pearce, E. N., & Bosch, N. A. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.8655 · Cited by 51
Self-citationThyroid disease assessment and management: summary of NICE guidance
Vasileiou, M., Gilbert, J., Fishburn, S., & Boelaert, K. (2020) · BMJ · doi:10.1136/bmj.m41 · Cited by 49
Donovan, P. J., McLeod, D. S. A., Little, R. F., & Gordon, L. G. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0527 · Cited by 48
Predictive factors of radioiodine therapy failure in Graves’ Disease: A meta-analysis
Shalaby, M., Hadedeya, D., Toraih, E. A., Razavi, M. A., Lee, G. S., Hussein, M. H., Weidenhaft, M. C., Serou, M. J., Ibraheem, K., Abdelgawad, M., et al. (2021) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2021.03.068 · Cited by 41
Park, S. Y., Kim, B. H., Kim, M., Hong, A. R., Park, J. T., Park, H., Choi, M. S., Kim, T. H., Kim, S. W., Kang, H., et al. (2021) · Endocrine · doi:10.1007/s12020-021-02725-x · Cited by 38
The effects of gestational transient thyrotoxicosis on the perinatal outcomes: a case–control study
Kinomoto, S., Umehara, N., SATO, S. T., Ogawa, K., Fujiwara, T., Arata, N., & Sago, H. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-016-4219-2 · Cited by 36
Demir, B. K., Karakılıç, E., Saygılı, E. S., Aracı, N., & Özdemir, S. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.05.001 · Cited by 34
Giesecke, P., Frykman, V., Wallin, G., Lönn, S., Discacciati, A., Törring, O., & Rosenqvist, M. A. (2017) · British journal of surgery · doi:10.1002/bjs.10665 · Cited by 33
Junior, J. M. A., Bernardo, W. M., Ward, L. S., & Villagelin, D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.800257 · Cited by 31
Racaru, L. V., Fontan, C., Bauriaud, M., Brillouet, S., Caselles, O., Zerdoud, S., Bastié, D., Vallot, D., Caron, P. J., Bardiès, M., et al. (2017) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000705 · Cited by 30
Tsai, C., Yang, P., Lee, J.-J., Liu, T., Kuo, C., & Cheng, S. (2019) · Otolaryngology · doi:10.1177/0194599819829052 · Cited by 30
Control of Graves’ hyperthyroidism with very long-term methimazole treatment: a clinical trial
Azizi, F., Abdi, H., & Amouzegar, A. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00670-w · Cited by 30
Morales, D. R., Fonkwen, L., & Nordeng, H. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14805 · Cited by 30
Revisiting the role of surgery in the treatment of Graves’ disease
Cohen, O. M., Ronen, O., Khafif, A., Rodrigo, J. P., Simó, R., Pace‐Asciak, P., Randolph, G. W., Mikkelsen, L. H., Kowalski, L. P., Olsen, K. D., et al. (2021) · Clinical Endocrinology · doi:10.1111/cen.14653 · Cited by 29
Increased incidence of Graves' disease during the SARS‐CoV2 pandemic
Galindo, D. E. B., Bachiller, B. R., Roza, L. G., de Morales, J. M. G. R., Lasheras, F. S., Arnáiz, E. G., Cobo, D. A., Ballesteros-Pomar, M. D., & Rodríguez, I. C. (2022) · Clinical Endocrinology · doi:10.1111/cen.14860 · Cited by 29
Brzozowska, M. M., & ROACH, P. J. (2006) · Clinical Nuclear Medicine · doi:10.1097/01.rlu.0000242600.23386.1a · Cited by 28
Tozzoli, R., Kodermaz, G., Villalta, D., Bagnasco, M., Pesce, G., & Bizzaro, N. (2010) · Autoimmunity Highlights · doi:10.1007/s13317-010-0014-4 · Cited by 27
Giesecke, P., Rosenqvist, M., Frykman, V., Friberg, L., Wallin, G., Höijer, J., Lönn, S., & Törring, O. (2017) · Thyroid · doi:10.1089/thy.2017.0029 · Cited by 27
Agrawal, M., Lewis, S., Premawardhana, L. D. K. E., Dayan, C. M., Taylor, P. N., & Okosieme, O. E. (2021) · Clinical Endocrinology · doi:10.1111/cen.14646 · Cited by 27
Radiofrequency Ablation and Autonomous Functioning Thyroid Nodules: Review of the Current Literature
Muhammad, H., Tehreem, A., Russell, J. O., & Tufano, R. P. (2021) · The Laryngoscope · doi:10.1002/lary.29811 · Cited by 22
Azizi, F., Abdi, H., Cheraghi, L., & Amouzegar, A. (2020) · Thyroid · doi:10.1089/thy.2020.0433 · Cited by 20
Methimazole Treatment and Risk of Acute Pancreatitis: A Population-based Cohort Study
Pecere, A., Caputo, M., Sarro, A., Ucciero, A., Zibetti, A., Aimaretti, G., Marzullo, P., & Barone‐Adesi, F. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa544 · Cited by 19
Chung, J. H. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.35.1.7 · Cited by 18
The role of laboratory medicine in the diagnosis of the hyperthyroidism
D’Aurizio, F. (2021) · The Quarterly Journal of Nuclear Medicine and Molecular Imaging · doi:10.23736/s1824-4785.21.03344-6 · Cited by 18
Emily, Z., Kuo, J. H., Malek, R., Turner, D. J., Olson, J. A., Slejko, J. F., Mullins, C. D., & Hu, Y. (2022) · Surgery · doi:10.1016/j.surg.2022.06.044 · Cited by 17
Viola, N., Brancatella, A., Sgrò, D., Santini, F., & Latrofa, F. (2022) · Endocrine · doi:10.1007/s12020-022-03247-w · Cited by 16
Therapeutic plasmapheresis for the treatment of thyrotoxicosis: A retrospective multi‐center study
Builes-Montaño, C. E., Arrieta, L. A. R., Román-Gonzaléz, A., Prieto, C., Álvarez-Payares, J. C., Barrera, C. A. B., & Toro, C. M. A. (2021) · Journal of Clinical Apheresis · doi:10.1002/jca.21927 · Cited by 15
Effect of Addition of Thyroxine in the Treatment of Graves’ Disease: A Systematic Review
Li, J., Bai, L., Wei, F., Wei, M., Xiao, Y., Yan, W., & Wei, J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.560157 · Cited by 14
Thyroid dysfunction on the heart: clinical effects, prognostic impact and management strategies
Mattesi, G., Michele, S. D., Mele, D., Rigato, I., Bariani, R., Fiorencis, A., Previtero, M., Sergani, A. A., Leoni, L., Bauce, B., et al. (2022) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2022.2145 · Cited by 12
Rahimi‐Bashar, F., Vahedian‐Azimi, A., Dalvand, S., Karimi, L., Moshkani, M., Alimohamadi, Y., Johnston, T. P., & Sahebkar, A. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220831145651 · Cited by 12
Methimazole discontinuation before radioiodine therapy in patients with Graves’ disease
Zakavi, S. R., Khazaei, G., Sadeghi, R., Ayati, N., Davachi, B., Bonakdaran, S., Nooghabi, M. J., & Mousavi, Z. (2015) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000384 · Cited by 9
Issa, P. P., Hussein, M. H., Omar, M., Munshi, R., Attia, A. S., Buti, Y. J., Aboueisha, M. A., Shama, M., Toraih, E. A., & Kandil, E. H. (2022) · Journal of Surgical Research · doi:10.1016/j.jss.2022.10.043 · Cited by 8
Patient needs and care: moves toward person-centered care for Graves' disease in Sweden
Lindo, A., Breikert, A., Lakwijk, P., Lundberg, C., Lunner, K., Johansson, B., & Nyström, H. F. (2023) · European Thyroid Journal · doi:10.1530/etj-23-0010 · Cited by 8
Mengistu, H. S., Getahun, K. T., Alemayehu, L., & Gezahagn, S. (2022) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s350984 · Cited by 5
Acute effect of propranolol on resting energy expenditure in hyperthyroid patients
Senn, J. R., Loeliger, R. C., Fischer, J., Bur, F., Maushart, C. I., & Betz, M. J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1026998 · Cited by 3
Cited by
Petit, P., Chamot, S., Al-Salameh, A., Cancé, C., Desailloud, R., & Bonneterre, V. (2024) · Environmental Research · doi:10.1016/j.envres.2024.118458 · Cited by 8
Metadata
- Authors
- Lee, S. Y., & Pearce, E. N.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2023-10-17
- Volume
- 330
- Issue
- 15
- Pages
- 1472
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W4387692307
- Cited by
- 295
- References
- 101
- FWCI
- 48.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.